Search research articles
Contact Us
Filters
Showing results (251-260 of 503) with videos related to
Page
of 51
Sort By:
Auto- Immunity Highlights
|
April 8, 2021
Short-chain fatty acids and intestinal inflammation in multiple sclerosis: modulation of female susceptibility by microbial products?
Anouck Becker, Mosab Abuazab, Andreas Schwiertz, et al.
JCO Clinical Cancer Informatics
|
January 19, 2019
History of Diabetes and Survival Outcome Among Participants 65 Years or Older in SWOG Clinical Trials
Dawn L Hershman, Cathee Till, Jason D Wright, et al.
The Lancet Regional Health. Western Pacific
|
July 30, 2021
The impact of the COVID-19 pandemic on health services utilization in China: Time-series analyses for 2016-2020
Hong Xiao, Xiaochen Dai, Bradley H Wagenaar, et al.
Journal of Neurology
|
March 3, 2009
Transcranial midbrain sonography in narcoleptic subjects with and without concomitant REM sleep behaviour disorder
Marcus M Unger, Jens C Möller, Tim Ohletz, et al.
General & Diagnostic Pathology
|
January 27, 1998
Villous cytotrophoblast proliferating potential in complete and partial hydatidiform mole: diagnostic value of silver-stained nucleolar organizer region (AgNOR)-associated proteins
H Neudeck, M Unger, P Hufnagl, et al.
JAMA Oncology
|
December 26, 2025
Baseline Fatigue and Severe Toxic Effects in Patients With Cancer Receiving Systemic Therapy
Joseph M Unger, Michael J Fisch, Salene M W Jones, et al.
JAMA Network Open
|
September 5, 2019
Association of National Cancer Institute-Sponsored Clinical Trial Network Group Studies With Guideline Care and New Drug Indications
Joseph M Unger, Van T Nghiem, Dawn L Hershman, et al.
European Journal of Neurology
|
August 22, 2008
Clinical risk-benefit assessment of dopamine agonists
J C Möller, K M Eggert, M Unger, et al.
Therapeutic Advances in Neurological Disorders
|
December 15, 2025
Alterations of fecal short-chain fatty acids solely in the course of multiple sclerosis: rethinking the gut-brain axis in the early stages of MS
Jakob Stögbauer, Niklas Kämpfer, Anouck Becker-Dorison, et al.
Blood
|
April 18, 1998
Granulocyte colony-stimulating factor worsens the outcome of experimental Klebsiella pneumoniae pneumonia through direct interaction with the bacteria
T K Held, M E Mielke, M Chedid, et al.
Page
of 51
Search research articles
Search
Showing results (251-260 of 503) with videos related to
Sort By:
Page
of 51
Auto- Immunity Highlights
|
April 8, 2021
Short-chain fatty acids and intestinal inflammation in multiple sclerosis: modulation of female susceptibility by microbial products?
Anouck Becker, Mosab Abuazab, Andreas Schwiertz, et al.
JCO Clinical Cancer Informatics
|
January 19, 2019
History of Diabetes and Survival Outcome Among Participants 65 Years or Older in SWOG Clinical Trials
Dawn L Hershman, Cathee Till, Jason D Wright, et al.
The Lancet Regional Health. Western Pacific
|
July 30, 2021
The impact of the COVID-19 pandemic on health services utilization in China: Time-series analyses for 2016-2020
Hong Xiao, Xiaochen Dai, Bradley H Wagenaar, et al.
Journal of Neurology
|
March 3, 2009
Transcranial midbrain sonography in narcoleptic subjects with and without concomitant REM sleep behaviour disorder
Marcus M Unger, Jens C Möller, Tim Ohletz, et al.
General & Diagnostic Pathology
|
January 27, 1998
Villous cytotrophoblast proliferating potential in complete and partial hydatidiform mole: diagnostic value of silver-stained nucleolar organizer region (AgNOR)-associated proteins
H Neudeck, M Unger, P Hufnagl, et al.
JAMA Oncology
|
December 26, 2025
Baseline Fatigue and Severe Toxic Effects in Patients With Cancer Receiving Systemic Therapy
Joseph M Unger, Michael J Fisch, Salene M W Jones, et al.
JAMA Network Open
|
September 5, 2019
Association of National Cancer Institute-Sponsored Clinical Trial Network Group Studies With Guideline Care and New Drug Indications
Joseph M Unger, Van T Nghiem, Dawn L Hershman, et al.
European Journal of Neurology
|
August 22, 2008
Clinical risk-benefit assessment of dopamine agonists
J C Möller, K M Eggert, M Unger, et al.
Therapeutic Advances in Neurological Disorders
|
December 15, 2025
Alterations of fecal short-chain fatty acids solely in the course of multiple sclerosis: rethinking the gut-brain axis in the early stages of MS
Jakob Stögbauer, Niklas Kämpfer, Anouck Becker-Dorison, et al.
Blood
|
April 18, 1998
Granulocyte colony-stimulating factor worsens the outcome of experimental Klebsiella pneumoniae pneumonia through direct interaction with the bacteria
T K Held, M E Mielke, M Chedid, et al.
Page
of 51